title: Transcriptomics and venomics: implications for medicinal chemistry.
abstract: Over the last three decades, transcriptomic studies of venom gland cells have continuously evolved, opening up new possibilities for exploring the molecular diversity of animal venoms, a prerequisite for the discovery of new drug candidates and molecular phylogenetics. The molecular complexity of animal venoms is much greater than initially thought. In this review, we describe the different technologies available for transcriptomic studies of venom, from the original individual cloning approaches to the more recent global Next Generation Sequencing strategies. Our understanding of animal venoms is evolving, with the discovery of complex and diverse bio-optimized cocktails of compounds, including mostly peptides and proteins, which are now beginning to be studied by academic and industrial researchers.
authors.affiliation: Department of ImmunoVirology, iMETI/DSV/CEA, Bt 02, 18 rue du Panorama, BP 6, 92265, Fontenay-aux-Roses, France.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Ducancel
authors.forename: Jordi
authors.initials: J
authors.lastname: Durban
authors.forename: Marion
authors.initials: M
authors.lastname: Verdenaud
mesh_terms: D000818:Animals; D055808:Drug Discovery; D020224:Expressed Sequence Tags; D020869:Gene Expression Profiling; D059014:High-Throughput Nucleotide Sequencing; D006801:Humans; D010146:Pain / Q000188:drug therapy; D059467:Transcriptome; D014688:Venoms / Q000378:metabolism* / Q000627:therapeutic use
chemical_list: D014688:Venoms